A Simple Quantitative Method for Monoclonal Antibody Coformulations

contributed by Phenomenex | 09/07/2023

Monoclonal antibodies (mAbs) are well-established therapeutics for a wide range of medical applications. Recent trends have investigated the administration of multiple mAbs with the goal of improving efficacy without sacrificing safety. Although coformulation approaches offer significant advantages, the complexity of drug product development, characterization, and quality control increase as well.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.